Blood pressure increase with impaired glucose tolerance in young adult American blacks

Hypertension

Volumn 34, Issue 5, 1999, Pages 1086-1090

  Falkner, Bonita ^a   Sherif, Katherine ^a   Sumner, Anne E ^a   Kushner, Harvey ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Blacks; Blood pressure; Diabetes mellitus; Glucose; Insulin; Lipids

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0032705140     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.5.1086     Document Type: Article

References (26)

1. Skyler JS, Marks JB, Schneiderman N. Hypertension in patients with diabetes mellitus. Am J Hypertens. 1995;8:100S-105S.
2. Gillum RF, Mussolino ME, Madans JH. Coronary heart disease incidence and survival in African-American women and men: the NHANES I Epidemiologic Follow-up Study. Ann Intern Med. 1997;127:111-118.
3. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
4. Falkner B, Kushner H, Tulenko T, Sumner AE, Marsh JB. Insulin sensitivity, lipids, and blood pressure in young African Americans. Arterioscler Thromb Vasc Biol. 1995A;15:1798-1804.
5. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
6. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1998;21(suppl 1):S5-S19.
7. Wormsley J, Durnin JV. A comparison of the skinfold method with extent of overweight and various height-weight relationships in assessment of obesity. Br J Nutr. 1977;38:271-284.
8. Bachorik PS, Walker RE, Virgil DG. High-density-lipoprotein cholesterol in heparin-MnC12 supernates determined with the Dow enzymic method after precipitation of Mn2+ with HC03-. Clin Chem. 1984;30:839-842.
9. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
10. DeFronzo R, Tobin J, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237: E214-E223.
11. Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol. 1981; 240:E630-E639.
12. Falkner B, Kushner H. The effect of chronic sodium loading on cardiovascular response in young blacks and whites. Hypertension. 1990;15: 36-43.
13. Kumanyika SK. Special issues regarding obesity in minority populations. Ann Intern Med. 1993; 119(pt 2):650-654.
14. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of glucose and insulin infusions on sympathetic nervous system activity in normal man. Diabetes. 1981;30:219-225.
15. DeFronzo RA. The effect of insulin on renal sodium metabolism. Diabetologia. 1981;21:165-171.
16. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyper-insulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246-2252.
17. Anderson EA, Balon TW, Hoffman RP, Sinkey CA, Mark AL. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension. 1992;18:621-627.
18. Falkner B, Hulmon S, Kushner H. Hyperinsulinemia and blood pressure sensitivity to sodium in young blacks. J Am Soc Nephrol. 1992;3: 940-946.
19. Hall JE, Brands MW, Mizelle HL, Gaillard DA, Hilderbrande DA. Chronic intrarenal hyperinsulinemia does not cause hypertension. Am J Physiol. 1991;260:F663-F669.
20. Hall JE, Brands MW, Dixon WN, Smith MJ Jr. Obesity induced hypertension renal function and systemic hemodynamics. Hypertension. 1993; 22:292-299.
21. Baron AD, Brechtel-Hook G, Johnson A, Hardin D. Skeletal muscle blood flow: a possible link between insulin resistance and blood pressure. Hypertension. 1993;21:129-135.
22. Laakso M, Edelman SV, Brechtel G, Baron AD. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes. 1992;41:1076-1083.
23. Heise T, Magnusson D, Heinemann L, Sawicki PT. Insulin resistance and the effect of insulin on blood pressure in essential hypertension. Hypertension. 1998;32:243-248.
24. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 1993;88:2510-2516.
25. Williams SB, Cusco JA, Roddy MA, Johnstone MT, Creager MA. Impaired nitric oxide-mediated vasodilation in patients with non-insulin dependent diabetes mellitus. J Am Coll Cardiol. 1996;27:567-574.
26. Margolis JR, Kannel WB, Feinleib M, Dawber TR, McNamara PM. Clinical features of unrecognized myocardial infarction: silent and symptomatic. Eighteen year follow-up: the Framingham study. Am J Cardiol. 1973;32:1-7.